{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:19:26Z","timestamp":1773926366480,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12022-021-09686-x","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T01:02:26Z","timestamp":1625274146000},"page":"501-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Analyzing Genetic Differences Between Sporadic Primary and Secondary\/Tertiary Hyperparathyroidism by Targeted Next-Generation Panel Sequencing"],"prefix":"10.1007","volume":"32","author":[{"given":"Yu Ah","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Cheol","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bong Kyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Young","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae Joung","family":"Sul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Ah","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon-Kyung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soyoung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-4234","authenticated-orcid":false,"given":"Joonhong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"key":"9686_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2215\/cjn.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913-921.\u00a0https:\/\/doi.org\/10.2215\/cjn.06040710","journal-title":"Clin J Am Soc Nephrol"},{"key":"9686_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1681\/asn.2006070771","volume":"18","author":"KJ Martin","year":"2007","unstructured":"Martin KJ, Gonzalez EA (2007) Metabolic bone disease in chronic kidney disease. Journal of the American Society of Nephrology : JASN 18:875-885.\u00a0https:\/\/doi.org\/10.1681\/asn.2006070771","journal-title":"Journal of the American Society of Nephrology : JASN"},{"key":"9686_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1457496919866015","volume":"109","author":"WY van der Plas","year":"2020","unstructured":"van der Plas WY, Noltes ME, van Ginhoven TM, Kruijff S (2020) Secondary and tertiary hyperparathyroidism: a narrative review. Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 109:271-278.\u00a0https:\/\/doi.org\/10.1177\/1457496919866015","journal-title":"Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society"},{"key":"9686_CR4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.suc.2009.06.011","volume":"89","author":"SC Pitt","year":"2009","unstructured":"Pitt SC, Sippel RS, Chen H (2009) Secondary and tertiary hyperparathyroidism, state of the art surgical management. The Surgical clinics of North America 89:1227-1239.\u00a0https:\/\/doi.org\/10.1016\/j.suc.2009.06.011","journal-title":"The Surgical clinics of North America"},{"key":"9686_CR5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/ki.2008.28","volume":"73","author":"KB Lauter","year":"2008","unstructured":"Lauter KB, Arnold A (2008) Mutational analysis of CDKN1B, a candidate tumor-suppressor gene, in refractory secondary\/tertiary hyperparathyroidism. Kidney Int 73:1137-1140.\u00a0https:\/\/doi.org\/10.1038\/ki.2008.28","journal-title":"Kidney Int"},{"key":"9686_CR6","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Cetani F (2011) Clinical practice. Primary hyperparathyroidism. The New England journal of medicine 365:2389-2397. https:\/\/doi.org\/10.1056\/NEJMcp1106636","journal-title":"The New England journal of medicine"},{"key":"9686_CR7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1055-3207(18)30242-4","volume":"7","author":"E Kebebew","year":"1998","unstructured":"Kebebew E, Clark OH (1998) Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis. Surgical oncology clinics of North America 7:721-748","journal-title":"Surgical oncology clinics of North America"},{"key":"9686_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hed.23656","volume":"37","author":"OA Segiet","year":"2015","unstructured":"Segiet OA, Deska M, Michalski M, Gawrychowski J, Wojnicz R (2015) Molecular profiling in primary hyperparathyroidism. Head & neck 37:299-307. https:\/\/doi.org\/10.1002\/hed.23656","journal-title":"Head & neck"},{"key":"9686_CR9","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1210\/jc.2005-0717","volume":"90","author":"LJ Krebs","year":"2005","unstructured":"Krebs LJ, Shattuck TM, Arnold A (2005) HRPT2 mutational analysis of typical sporadic parathyroid adenomas. The Journal of clinical endocrinology and metabolism 90:5015-5017. https:\/\/doi.org\/10.1210\/jc.2005-0717","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"9686_CR10","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1210\/jc.2012-4029","volume":"98","author":"E Pardi","year":"2013","unstructured":"Pardi E, Marcocci C, Borsari S, Saponaro F, Torregrossa L, Tancredi M, Raspini B, Basolo F, Cetani F (2013) Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. The Journal of clinical endocrinology and metabolism 98:2800-2810. https:\/\/doi.org\/10.1210\/jc.2012-4029","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"9686_CR11","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1210\/jc.2008-2430","volume":"95","author":"V Guarnieri","year":"2010","unstructured":"Guarnieri V, Canaff L, Yun FH, Scillitani A, Battista C, Muscarella LA, Wong BY, Notarangelo A, D\u2019Agruma L, Sacco M, Cole DE, Hendy GN (2010) Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years. The Journal of clinical endocrinology and metabolism 95:1819-1829.\u00a0https:\/\/doi.org\/10.1210\/jc.2008-2430","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"9686_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12672-013-0147-9","volume":"4","author":"J Costa-Guda","year":"2013","unstructured":"Costa-Guda J, Soong CP, Parekh VI, Agarwal SK, Arnold A (2013) Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas. Hormones & cancer 4:301-307.\u00a0https:\/\/doi.org\/10.1007\/s12672-013-0147-9","journal-title":"Hormones & cancer"},{"key":"9686_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1210\/jc.2006-1197","volume":"92","author":"P Bj\u00f6rklund","year":"2007","unstructured":"Bj\u00f6rklund P, Akerstr\u00f6m G, Westin G (2007) Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors. The Journal of clinical endocrinology and metabolism 92:338-344. https:\/\/doi.org\/10.1210\/jc.2006-1197","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"9686_CR14","doi-asserted-by":"publisher","first-page":"E1774","DOI":"10.1210\/jc.2012-1743","volume":"97","author":"MK Cromer","year":"2012","unstructured":"Cromer MK, Starker LF, Choi M, Udelsman R, Nelson-Williams C, Lifton RP, Carling T (2012) Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. The Journal of clinical endocrinology and metabolism 97:E1774-1781. https:\/\/doi.org\/10.1210\/jc.2012-1743","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"9686_CR15","doi-asserted-by":"publisher","first-page":"E1995","DOI":"10.1210\/jc.2012-2303","volume":"97","author":"PJ Newey","year":"2012","unstructured":"Newey PJ, Nesbit MA, Rimmer AJ, Attar M, Head RT, Christie PT, Gorvin CM, Stechman M, Gregory L, Mihai R, Sadler G, McVean G, Buck D, Thakker RV (2012) Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas. The Journal of clinical endocrinology and metabolism 97:E1995-2005. https:\/\/doi.org\/10.1210\/jc.2012-2303","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"9686_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mce.2013.09.005","volume":"386","author":"J Costa-Guda","year":"2014","unstructured":"Costa-Guda J, Arnold A (2014) Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors. Molecular and cellular endocrinology 386:46-54.\u00a0https:\/\/doi.org\/10.1016\/j.mce.2013.09.005","journal-title":"Molecular and cellular endocrinology"},{"key":"9686_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09656-9","author":"CC Juhlin","year":"2020","unstructured":"Juhlin CC, Erickson LA (2020) Genomics and epigenomics in parathyroid neoplasia: from bench to surgical pathology practice. Endocr Pathol. https:\/\/doi.org\/10.1007\/s12022-020-09656-9","journal-title":"Endocr Pathol."},{"key":"9686_CR18","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1530\/ec-17-0283","volume":"7","author":"M Mizamtsidi","year":"2018","unstructured":"Mizamtsidi M, Nastos C, Mastorakos G, Dina R, Vassiliou I, Gazouli M, Palazzo F (2018) Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks. Endocr Connect 7:R56-r68. https:\/\/doi.org\/10.1530\/ec-17-0283","journal-title":"Endocr Connect"},{"key":"9686_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/joim.12458","volume":"280","author":"G Westin","year":"2016","unstructured":"Westin G (2016) Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours. Journal of internal medicine 280:551-558.\u00a0https:\/\/doi.org\/10.1111\/joim.12458","journal-title":"Journal of internal medicine"},{"key":"9686_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.beem.2018.11.001","volume":"32","author":"L Cinque","year":"2018","unstructured":"Cinque L, Pugliese F, Salcuni AS, Scillitani A, Guarnieri V (2018) Molecular pathogenesis of parathyroid tumours. Best practice & research Clinical endocrinology & metabolism 32:891-908. https:\/\/doi.org\/10.1016\/j.beem.2018.11.001","journal-title":"Best practice & research Clinical endocrinology & metabolism"},{"key":"9686_CR21","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1210\/en.2018-00246","volume":"159","author":"Z Wei","year":"2018","unstructured":"Wei Z, Sun B, Wang ZP, He JW, Fu WZ, Fan YB, Zhang ZL (2018) Whole-exome sequencing identifies novel recurrent somatic mutations in sporadic parathyroid adenomas. Endocrinology 159:3061-3068. https:\/\/doi.org\/10.1210\/en.2018-00246","journal-title":"Endocrinology"},{"key":"9686_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. The Journal of molecular diagnostics : JMD 19:4-23. https:\/\/doi.org\/10.1016\/j.jmoldx.2016.10.002","journal-title":"The Journal of molecular diagnostics : JMD"},{"key":"9686_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1101\/gr.097857.109","volume":"20","author":"KS Pollard","year":"2010","unstructured":"Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A (2010) Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 20:110-121. https:\/\/doi.org\/10.1101\/gr.097857.109","journal-title":"Genome Res"},{"key":"9686_CR24","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/humu.20892","volume":"29","author":"SV Tavtigian","year":"2008","unstructured":"Tavtigian SV, Greenblatt MS, Lesueur F, Byrnes GB (2008) In silico analysis of missense substitutions using sequence-alignment based methods. Hum Mutat 29:1327-1336. https:\/\/doi.org\/10.1002\/humu.20892","journal-title":"Hum Mutat"},{"key":"9686_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/jcem.76.1.8421078","volume":"76","author":"A Falchetti","year":"1993","unstructured":"Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Bandini S, Marx SJ, Brandi ML (1993) Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. The Journal of clinical endocrinology and metabolism 76:139-144. https:\/\/doi.org\/10.1210\/jcem.76.1.8421078","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"9686_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/oxfordjournals.ndt.a027829","volume":"13","author":"C Inagaki","year":"1998","unstructured":"Inagaki C, Dousseau M, Pacher N, Sarfati E, Dr\u00fceke TB, Gogusev J (1998) Structural analysis of gene marker loci on chromosomes 10 and 11 in primary and secondary uraemic hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 13:350-357. https:\/\/doi.org\/10.1093\/oxfordjournals.ndt.a027829","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"9686_CR27","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/01.asn.0000018148.50109.c0","volume":"13","author":"Y Imanishi","year":"2002","unstructured":"Imanishi Y, Tahara H, Palanisamy N, Spitalny S, Salusky IB, Goodman W, Brandi ML, Dr\u00fceke TB, Sarfati E, Ure\u00f1a P, Chaganti RS, Arnold A (2002) Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia. Journal of the American Society of Nephrology : JASN 13:1490-1498. https:\/\/doi.org\/10.1097\/01.asn.0000018148.50109.c0","journal-title":"Journal of the American Society of Nephrology : JASN"},{"key":"9686_CR28","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1007\/s00268-009-0022-6","volume":"33","author":"G Westin","year":"2009","unstructured":"Westin G, Bjorklund P, Akerstrom G (2009) Molecular genetics of parathyroid disease. World journal of surgery 33:2224-2233.\u00a0https:\/\/doi.org\/10.1007\/s00268-009-0022-6","journal-title":"World journal of surgery"},{"key":"9686_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"MC Lemos","year":"2008","unstructured":"Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22-32.\u00a0https:\/\/doi.org\/10.1002\/humu.20605","journal-title":"Hum Mutat"},{"key":"9686_CR30","first-page":"5553","volume":"60","author":"S Uchino","year":"2000","unstructured":"Uchino S, Noguchi S, Sato M, Yamashita H, Yamashita H, Watanabe S, Murakami T, Toda M, Ohshima A, Futata T, Mizukoshi T, Koike E, Takatsu K, Terao K, Wakiya S, Nagatomo M, Adachi M (2000) Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 60:5553-5557","journal-title":"Cancer Res"},{"key":"9686_CR31","first-page":"35","volume":"34","author":"F Cetani","year":"2011","unstructured":"Cetani F, Pardi E, Borsari S, Marcocci C (2011) Molecular pathogenesis of primary hyperparathyroidism. J Endocrinol Invest 34:35-39","journal-title":"J Endocrinol Invest"},{"key":"9686_CR32","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00268-009-0388-5","volume":"34","author":"A Skandarajah","year":"2010","unstructured":"Skandarajah A, Barlier A, Morlet-Barlat N, Sebag F, Enjalbert A, Conte-Devolx B, Henry JF (2010) Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age? World journal of surgery 34:1294-1298. https:\/\/doi.org\/10.1007\/s00268-009-0388-5","journal-title":"World journal of surgery"},{"key":"9686_CR33","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1210\/en.2004-0959","volume":"145","author":"M Fu","year":"2004","unstructured":"Fu M, Wang C, Li Z, Sakamaki T, Pestell RG (2004) Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145:5439-5447. https:\/\/doi.org\/10.1210\/en.2004-0959","journal-title":"Endocrinology"},{"key":"9686_CR34","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1007\/s00268-014-2455-9","volume":"38","author":"L Zhao","year":"2014","unstructured":"Zhao L, Sun LH, Liu DM, He XY, Tao B, Ning G, Liu JM, Zhao HY (2014) Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadic parathyroid carcinoma. World journal of surgery 38:1730-1737. https:\/\/doi.org\/10.1007\/s00268-014-2455-9","journal-title":"World journal of surgery"},{"key":"9686_CR35","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.060025397","volume":"97","author":"SY Lin","year":"2000","unstructured":"Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC (2000) Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proceedings of the National Academy of Sciences of the United States of America 97:4262-4266. https:\/\/doi.org\/10.1073\/pnas.060025397","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9686_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/pas.0000000000001017","volume":"43","author":"AJ Gill","year":"2019","unstructured":"Gill AJ, Lim G, Cheung VKY, Andrici J, Perry-Keene JL, Paik J, Sioson L, Clarkson A, Sheen A, Luxford C, Elston MS, Meyer-Rochow GY, Nano MT, Kruijff S, Engelsman AF, Sywak M, Sidhu SB, Delbridge LW, Robinson BG, Marsh DJ, Toon CW, Chou A, Clifton-Bligh RJ (2019) Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features. Am J Surg Pathol 43:35-46. https:\/\/doi.org\/10.1097\/pas.0000000000001017","journal-title":"Am J Surg Pathol"},{"key":"9686_CR37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12022-020-09631-4","volume":"31","author":"J Turchini","year":"2020","unstructured":"Turchini J, Gill AJ (2020) Hereditary parathyroid disease: sometimes pathologists do not know what they are missing. Endocr Pathol 31:218-230. https:\/\/doi.org\/10.1007\/s12022-020-09631-4","journal-title":"Endocr Pathol"},{"key":"9686_CR38","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath H, 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nature genetics 32:676-680.\u00a0https:\/\/doi.org\/10.1038\/ng1048","journal-title":"Nature genetics"},{"key":"9686_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. Journal of medical genetics 40:657-663. https:\/\/doi.org\/10.1136\/jmg.40.9.657","journal-title":"Journal of medical genetics"},{"key":"9686_CR40","first-page":"1617","volume":"24","author":"M Katoh","year":"2004","unstructured":"Katoh M, Katoh M (2004) Identification and characterization of ASXL3 gene in silico. International journal of oncology 24:1617-1622","journal-title":"International journal of oncology"},{"key":"9686_CR41","doi-asserted-by":"publisher","unstructured":"Micol JB, Abdel-Wahab O (2016) The role of additional sex combs-like proteins in cancer. Cold Spring Harbor perspectives in medicine 6. https:\/\/doi.org\/10.1101\/cshperspect.a026526","DOI":"10.1101\/cshperspect.a026526"},{"key":"9686_CR42","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","volume":"150","author":"M Imielinski","year":"2012","unstructured":"Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, Sougnez C, Auclair D, Lawrence MS, Stojanov P, Cibulskis K, Choi K, de Waal L, Sharifnia T, Brooks A, Greulich H, Banerji S, Zander T, Seidel D, Leenders F, Ansen S, Ludwig C, Engel-Riedel W, Stoelben E, Wolf J, Goparju C, Thompson K, Winckler W, Kwiatkowski D, Johnson BE, Janne PA, Miller VA, Pao W, Travis WD, Pass HI, Gabriel SB, Lander ES, Thomas RK, Garraway LA, Getz G, Meyerson M (2012) Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150:1107-1120. https:\/\/doi.org\/10.1016\/j.cell.2012.08.029","journal-title":"Cell"},{"key":"9686_CR43","doi-asserted-by":"publisher","unstructured":"Laugesen A, H\u00f8jfeldt JW, Helin K (2016) Role of the polycomb repressive complex 2 (PRC2) in transcriptional regulation and cancer. Cold Spring Harbor perspectives in medicine 6. https:\/\/doi.org\/10.1101\/cshperspect.a026575","DOI":"10.1101\/cshperspect.a026575"},{"key":"9686_CR44","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ng.621","volume":"42","author":"T Ernst","year":"2010","unstructured":"Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV, Waghorn K, Zoi K, Ross FM, Reiter A, Hochhaus A, Drexler HG, Duncombe A, Cervantes F, Oscier D, Boultwood J, Grand FH, Cross NC (2010) Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nature genetics 42:722-726. https:\/\/doi.org\/10.1038\/ng.621","journal-title":"Nature genetics"},{"key":"9686_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ng.620","volume":"42","author":"G Nikoloski","year":"2010","unstructured":"Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, Tonnissen ER, van der Heijden A, Scheele TN, Vandenberghe P, de Witte T, van der Reijden BA, Jansen JH (2010) Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nature genetics 42:665-667. https:\/\/doi.org\/10.1038\/ng.620","journal-title":"Nature genetics"},{"key":"9686_CR46","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","volume":"117","author":"DB Yap","year":"2011","unstructured":"Yap DB, Chu J, Berg T, Schapira M, Cheng SW, Moradian A, Morin RD, Mungall AJ, Meissner B, Boyle M, Marquez VE, Marra MA, Gascoyne RD, Humphries RK, Arrowsmith CH, Morin GB, Aparicio SA (2011) Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117:2451-2459. https:\/\/doi.org\/10.1182\/blood-2010-11-321208","journal-title":"Blood"},{"key":"9686_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1530\/erc-13-0497","volume":"21","author":"J Svedlund","year":"2014","unstructured":"Svedlund J, Barazeghi E, St\u00e5lberg P, Hellman P, \u00c5kerstr\u00f6m G, Bj\u00f6rklund P, Westin G (2014) The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors. Endocrine-related cancer 21:231-239. https:\/\/doi.org\/10.1530\/erc-13-0497","journal-title":"Endocrine-related cancer"},{"key":"9686_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11083","volume":"485","author":"CC Thoreen","year":"2012","unstructured":"Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485:109-113. https:\/\/doi.org\/10.1038\/nature11083","journal-title":"Nature"},{"key":"9686_CR49","doi-asserted-by":"publisher","unstructured":"Pandya C, Uzilov AV, Bellizzi J, Lau CY, Moe AS, Strahl M, Hamou W, Newman LC, Fink MY, Antipin Y, Yu W, Stevenson M, Cavaco BM, Teh BT, Thakker RV, Morreau H, Schadt EE, Sebra R, Li SD, Arnold A, Chen R (2017) Genomic profiling reveals mutational landscape in parathyroid carcinomas. JCI insight 2:e92061.\u00a0https:\/\/doi.org\/10.1172\/jci.insight.92061","DOI":"10.1172\/jci.insight.92061"},{"key":"9686_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cancergen.2015.12.004","volume":"209","author":"K Geiersbach","year":"2016","unstructured":"Geiersbach K, Adey N, Welker N, Elsberry D, Malmberg E, Edwards S, Downs-Kelly E, Salama M, Bronneet M (2016) Digitally guided microdissection aids somatic mutation detection in difficult to dissect tumors. Cancer Genet 209: 42-49.\u00a0https:\/\/doi.org\/10.1016\/j.cancergen.2015.12.004","journal-title":"Cancer Genet"},{"key":"9686_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4143\/crt.2019.036","volume":"52","author":"H Shin","year":"2020","unstructured":"Shin H, Sa JK, Bae JS, Koo H, Jin S, Cho HJ, Choi SW, Kyoung JM, Kim JY, Seo YJ, Joung JG, Kim NKD, Son DS, Chung J, Lee T, Kong DS, Choi JW, Seol HJ, Lee JI, Suh YL, Park WY, Nam DH (2020) Clinical targeted next-generation sequencing panels for detection of somatic variants in gliomas. Cancer research and treatment : official journal of Korean Cancer Association 52:41-50. https:\/\/doi.org\/10.4143\/crt.2019.036","journal-title":"Cancer research and treatment : official journal of Korean Cancer Association"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09686-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-021-09686-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09686-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T19:15:53Z","timestamp":1637608553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-021-09686-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9686"],"URL":"https:\/\/doi.org\/10.1007\/s12022-021-09686-x","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,3]]},"assertion":[{"value":"7 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of The Catholic University of Korea (DC19SESI0016). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}